Two new neolignans selaginellol (1) and selaginellol 4 0 -O-b-D-glucopyranoside (2), together with seven known compounds (3-9), were isolated from the whole plant of Selaginella moellendorffii. The structures of the new isolates were determined through spectroscopic data analysis. Compounds 1-9, as well as compounds 10-18 previously isolated from the species, were measured for the activity against platelet aggregation induced by ADP or collagen. Three neoligans (8, 11, and 12), one flavanone (14), and one alkaloid (16) showed inhibitory activity against ADP-or collagen-induced platelet aggregation as compared with tirofiban. The dihydrobenzofuran neolignans (8, 11, and 12) are more potent than the benzofuran neolignan (13) and other types of neolignans (1-7). Glucosidation of the dihydrobenzofuran neolignans (11 and 12) is helpful for the activity. Graphical Abstract Two new neolignans selaginellol (1) and selaginellol 4 0 -O-b-D-glucopyranoside (2) were isolated from the whole plant of Selaginella moellendorffii. Several compounds from this plant showed the activity against platelet aggregation induced by ADP or collagen.
genus of about 700 species, with 72 of them in China and more than 20 species used in traditional Chinese medicine [1, 2] . Several Selaginella species including S. delicatula (Desv. ex Poir.) Alston, S. moellendorffii Hieron., S. nipponica Franch. & Sav., S. sanguinolenta (L.) Spring, S. stauntoniana Spring, and S. tamariscina (P. Beauv.) Spring are used in promotion of blood circulation (Huoxue in Chinese) [1] . Traditional Chinese medicines with the functions of ''Huoxue'' and/or ''Huayu'' (removing blood stasis) are claimed to be useful in antiplatelet therapies and the treatment of thrombotic diseases [3, 4] . Previously, a pyrrolidinoindoline alkaloid selaginellic acid with antiplatelet activity was found from the whole plant of S. moellendorffii [5, 6] . This result prompted us to further investigate the plant which led to the isolation of nine compounds (1-9, Fig. 1 ) including two new neolignans (1 and 2). Compounds 1-9, as well as those (10-18) previously isolated from the plant [5, 7, 8] , were evaluated for antiplatelet activity. The structural elucidation of the new compounds and the bioassay results are reported.
Results and Discussion
The HRESIMS analysis of selaginellol (1) gave an [M?Na] ? ion at m/z 415.1729 appropriate for a molecular formula of C 21 H 28 O 7 requiring eight sites of unsaturation. The IR absorption signals revealed the presence of hydroxy (3428 cm -1 ) and aromatic (1614, 1518, 1496, and 1461 cm -1 ) groups. The 1 H NMR data of 1 (Table 1) exhibited three methoxy groups [d H 3.82 (3H, s) and 3.70 (6H, s)], and two 1,2,3,5-tetrasubstituted benzene rings [d H 6.30 (2H, s); 6.63 (d, J = 1.6 Hz) and 6.47 (d, J = 1.6 Hz)]. The 13 C NMR data of 1 (Table 1) showed the signals for three methoxy groups (d C 56.5 9 2 and 56.4), two phenyl rings, five methylenes including two oxygenated ones (d C 65.9, 62.2, 37.9, 35.8, and 32.8), and one methine (d C 45.4). According to above NMR signal characteristics [8] , compound 1 might be a neolignan.
The 1 H-1 H COSY correlations ( Fig. 2 ) exhibited two partial structures from C-7 to C-9 and C-7 0 to C-9 0 . Based on the HMBC correlations ( Fig. 2 ) from H-2 and H-6 to C-4, H 2 -7 to C-2 and C-6, H-8 to C-1, H 2 -8 0 to C-1 0 , H 2 -7 0 to C-2 0 and C-6 0 , H-2 0 and H-6 0 to C-4 0 , 3-OMe to C-3, 5-OMe to C-5, and 5 0 -OMe to C-5 0 , two phenylpropanoid moieties, namely 4-(3-hydroxypropyl)-2,6-dimethoxyphenol and 4-(3-hydroxypropyl)-2-methoxyphenol, were confirmed. The two fragments were linked through C-8-C-3 0 by the HMBC correlations from H 2 -7 and H 2 -9 to C-3 0 as well as H-8 to C-2 0 and H-2 0 to C-8. Therefore, the relative configuration of 1 was elucidated as 3,5,5 0 -trimethoxy-8,3 0neoligna-4,4 0 ,9,9 0 -tetraol. H HO Fig. 1 The chemical structures of 1-9 from Selaginella moellendorffii selaginellol (1) was elucidated as (8R)-3,5,5 0 -trimethoxy-8,3 0 -neoligna-4,4 0 ,9,9 0 -tetraol by comparing its electronic circular dichroism (ECD) spectrum [De -0.12 (273)] with that of a known analogue secodihydrodehydrodiconiferyl alcohol tetraacetate [9] .
According to the HREIMS ion at m/z 554.2365 [M] ? (calcd for C 27 H 38 O 12 , 554.2363), the molecular formula of compound 2 was determined as C 27 H 38 O 12 with nine degrees of unsaturation. The IR absorption signals showed the presence of hydroxy (3425 cm -1 ) and aromatic (1614, (Fig. 2) , compound 2 was determined to be the b-glucopyranoside of selaginellol (1) . The HMBC correlation from H-1 00 to C-4 0 indicated that the b-glucopyranosyl part was located at C-4 0 . According to our previously acidic hydrolysis of rel-(7R,8S)-3,3 0 ,5-trimethoxy-4 0 ,7epoxy-8,5 0 -neoligna-4,9,9 0 -triol 4-O-b-D-glucopyranoside (11) [8] , the sugar in the plant is D-glucose. The absolute configuration of the aglycone was elucidated to be the same as that of selaginellol (1) by comparison of its ECD spectrum [De -0.37 (273)] with that of 1. Therefore,
The known compounds were determined as (-)-syringaresinol (3) [10] , (-)-lariciresinol (4) [11] , 7S,7 0 S,8R,8 0 R-icariol A 2 (5) [12] , lyoniside (6) [13] , (-)-8,8 0 -bisdihydrosiringenin (7) [14] , (7S,8R)-3,3 0 ,5-trimethoxy-4 0 ,7-epoxy-8,5 0 -neoligna-4,9,9 0 -triol (8) [8] , and dihydrosinapyl alcohol (9) [15] , by comparing their NMR data (for all known compounds) and optical rotation values (for the neolignans) with those reported in the literature.
All of these compounds (1-9), along with those previously isolated from the plant, including (7S,8R)-4,9-dihydroxy-3,3 0 ,5-trimethoxy-4 0 ,7-epoxy-8,5 0 -neolignan-9 0 -oic acid methyl ester (10) [8] , paucine (17) [8] , and N 1 -cis-p-coumaroylagmatine (18) [8] , were evaluated for the inhibitory activity against platelet aggregation induced by ADP or collagen. As shown in Table 2 , compounds 8, 11, 12, 14, and 16 showed potential inhibitory activity against ADP-induced platelet aggregation with IC 50 values of 80.84, 35.76, 42.47, 27.70, and 59.19 lM, respectively, as compared with the positive control tirofiban (IC 50 = 25.32 lM). Compounds 8, 11, 12, and 14 also showed the activity against collagen-induced platelet aggregation with IC 50 values of 146.70, 31.17, 24.57, and 26.25 lM, respectively, as compared with the positive control tirofiban (IC 50 = 148.20 lM). The dihydrobenzofuran neolignans (8, 11, and 12) are more potent than the benzofuran neolignan (13) and other types of neolignans (1) (2) (3) (4) (5) (6) (7) . Glucosidation of the dihydrobenzofuran neolignans (11 and 12) is helpful for the activity as compared the bioassay result of 11 and 12 with that of 8.
Experimental Section

General Experimental Procedures
Optical rotations were recorded using a JASCO P-1020 Polarimeter (Jasco Corp., Tokyo, Japan). UV spectra were taken on a Shimadzu UV-2401 PC spectrophotometer (Shimadzu, Kyoto, Japan). ECD spectra were recorded on a Chirascan CD spectrometer (Applied Photophysics Ltd., Leatherhead, UK). IR spectra were measured on a Bruker Tensor 27 FTIR Spectrometer (Bruker Corp., Ettlingen, Germany) with KBr disks. 1 H and 13 C NMR spectra were collected on Bruker Avance 400, DRX-500 or Avance III-600 spectrometers (Bruker Bio-Spin GmbH, Rheinstetten, Germany) with TMS as an internal standard. ESIMS and HRESIMS analyses were carried out on an API QSTAR Pulsar 1 spectrometer (Applied Biosystems/MDS Sciex, Foster City, CA, USA). HREIMS were carried out on a Waters AutoSpec Premier p776 spectrometer (Waters, Millford, MA, USA). Silica gel G (80-100 and 300-400 mesh, Qingdao Meigao Chemical Co., Ltd., Qingdao, China), C 18 silica gel (40-75 lm, Fuji Silysia Chemical Ltd., Aichi, Japan), Sephadex LH-20 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden), and D 101 macroporous resin (Qingdao Marine Chemical Ltd., Qingdao, China) were used for column chromatography, and silica gel GF 254 (Qingdao Meigao Chemical Co., Ltd.) was used for preparative TLC as precoated plates. TLC spots were visualized under UV light at 254 nm and by dipping into 5 % H 2 SO 4 in alcohol followed by heating. Semipreparative HPLC was performed on an Agilent 1200 series pump (Agilent Technologies, Santa Clara, USA) equipped with a diode array detector and an Agilent Zorbax SB-C 18 column (5.0 lm, / 9.4 9 250 mm).
Plant Material
The whole plant of S. moellendorffii was collected from Jingxi County of Guangxi Zhuang Autonomous Region in 
In Vitro Platelet Aggregation Assay
In vitro platelet aggregation was conducted using the turbidimetric method with a minor modification [16, 17] .
Briefly, blood was withdrawn from the carotid artery of New Zealand rabbits,and anticoagulated with 3.8 % sodium citrate (1:9 citrate/blood, v/v) and centrifuged for 15 min at 950 rpm to prepare platelet-rich plasma (PRP) or 10 min at 3000 rpm to obtain platelet-poor plasma (PPP). The platelet concentration was adjusted to 3 9 10 8 platelets/mL. PRP in 270 lL was preincubated at 37°C for 5 min in the cuvette with 20 lL of sample or vehicle (saline), and then platelet aggregation was induced by 10 lL ADP (10 lM) or collagen (2.5 lg/mL). The maximum platelet aggregation rate was determined within 5 min with continuous stirring at 37°C using four-channel aggregometer (Beijing Steellex Science Instrument Company, China). For each compound, five concentrations were chosen and a percentage inhibition-concentration curve was derived. From this curve the IC 50 value was calculated as the concentration of inhibitor causing a 50 % inhibition of the aggregation using SPSS software.
